Upstream Bio Stock

upstreambio.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $400MM

Upstream Bio, founded in 2021, is a biotechnology company with the goal of advancing the medical field through genetic technologies and computational methods. Their work predominantly revolves around aiming to develop novel therapeutics for challenging diseases, pushing boundaries in personalized medicine and genomics, and striving for breakthroughs that could significantly enhance human health and lifespan.

Register for Details

For more details on financing and valuation for Upstream Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Upstream Bio.

Register Today

Other companies like Upstream Bio in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
Upstream Bio, a clinical-stage biotech company advancing new therapies to treat inflammation, today announced the completion of a $200 million Series B financing.
Updated on: Sep 22, 2023